HOMOLOGOUS SERUM HEPATITIS
Authors: J W ROBINSON, D N TWADDELL, W P HAVEN
Journal: Annals of Internal Medicine (1950)

Article1 June 1950HOMOLOGOUS SERUM HEPATITISJAMES W. ROBINSON, M.D., DONALD N. TWADDELL, M.D., W. PAUL HAVENS JR., M.D.JAMES W. ROBINSON, M.D.Search for more papers by this author, DONALD N. TWADDELL, M.D.Search for more papers by this author, W. PAUL HAVENS JR., M.D.Search for more papers by this authorAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-32-6-1019 SectionsAboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail ExcerptHomologous serum hepatitis has been classified as a viral disease, transmitted by the parenteral inoculation of human blood or its products obtained from carriers of the causative virus. The exact relationship of thisartificially transmitteddisease to thenaturally occurringinfectious hepatitis is not known, and the question has been raised as to whether homologous serum hepatitis is not merely the result of the artificial transmission of a virus which, under natural conditions, causes sporadic or epidemic infectious hepatitis.1This is probably true more often than is suspected, although there is no evidence to indicate that it is always the...Bibliography1. AycockOren WLWF: Prolonged incubation period as an epidemiologic principle. Infectious hepatitis and homologous serum jaundice, Am. J. M. Sc. 214: 483-492, 1947. CrossrefMedlineGoogle Scholar2. Havens WP: The etiology of infectious hepatitis, J. A. M. A. 134: 653-655, 1947. CrossrefMedlineGoogle Scholar3. NeefeGellisStokes JRSSJ: Homologous serum hepatitis and infectious (epidemic) hepatitis: studies in volunteers bearing on immunological and other characteristics of etiological agents, Am. J. Med. 1: 3-22, 1946. CrossrefMedlineGoogle Scholar4. Role of syringes in transmission of jaundice. A Memorandum by Medical Officers of the Ministry of Health, Lancet 2: 116, 1945. Google Scholar5. MendelssohnWitts KLJ: Transmission of infection during withdrawal of blood, Brit. M. J. 1: 625-626, 1945. CrossrefMedlineGoogle Scholar6. DarmadyHardwick EMC: Syringe-transmitted hepatitis, Lancet 2: 106, 1945. CrossrefGoogle Scholar7. CappsSborovScheiffley RBVCS: A syringe-transmitted epidemic of infectious hepatitis with observations regarding the incidence and nature of infectious donors, J. A. M. A. 136: 819-824, 1948. CrossrefMedlineGoogle Scholar8. Propert SA: Hepatitis after prophylactic serum, Brit. M. J. 2: 677-678, 1938. CrossrefGoogle Scholar9. BeesonChesneyMcFarlan PBGAM: Hepatitis following injection of mumps convalescent plasma, Lancet 1: 814-821, 1944. CrossrefGoogle Scholar10. SawyerMeyerEatonBauerPutnamSchwentker WAKFMDJHPFF: Jaundice in Army personnel in the western region of the United States and its relation to vaccination against yellow fever. Part I, Am. J. Hyg. 39: 337-430, 1944; Parts II, III and IV, Am. J. Hyg. 40: 35-107, 1944. Google Scholar11. FindlayMartinMitchell GMNHJB: Hepatitis after yellow fever inoculation; relation to infective hepatitis, Lancet 2: 301-307, 340-344, 365-370, 1944. CrossrefGoogle Scholar12. Hepatitis after transfusion (Editorial), Brit. M. J. 2: 279, 1944. CrossrefMedlineGoogle Scholar13. Sartwell PE: Infectious hepatitis in relation to blood transfusion, Bull. U. S. Army Med. Dept. 7: 90-100, 1947. MedlineGoogle Scholar14. GrossmanSaward CMEW: Homologous serum jaundice following the administration of commercial pooled plasma, New Eng. J. Med. 234: 181-183, 1946. CrossrefMedlineGoogle Scholar15. Rosenthal LT: Homologous serum hepatitis in a civilian hospital, Gastroenterology 9: 28-32, 1947. MedlineGoogle Scholar16. ScheinbergKinneyJaneway HTDCA: Homologous serum jaundice. A problem in the operation of blood banks, J. A. M. A. 134: 841-848, 1947. CrossrefMedlineGoogle Scholar17. BrightmanKorns IJRF: Homologous serum jaundice in recipients of pooled plasma, J. A. M. A. 135: 268-272, 1947. CrossrefMedlineGoogle Scholar18. SpurlingShoneVaughan NJJ: Incidence, incubation period, and symptomatology of homologous serum jaundice, Brit. M. J. 2: 409-412, 1946. CrossrefGoogle Scholar19. BlanchardStokesHampilWadeSpizizen MCJBGRJ: Methods of protection against homologous serum hepatitis. II. The inactivation of hepatitis virus SH with ultraviolet rays, J. A. M. A. 138: 341-343, 1948. CrossrefMedlineGoogle Scholar This content is PDF only. To continue reading please click on the PDF icon. Author, Article, and Disclosure InformationAffiliations: *Received for publication April 28, 1949.From The Pennsylvania Hospital and The Jefferson Medical College, Philadelphia.This investigation was conducted, in part, with the aid of the Commission on Virus and Rickettsial Diseases, Armed Forces Epidemiological Board, Office of The Surgeon General, U. S. Army, Washington, D. C. PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetails Metrics Cited byA Note on Fatality in Serum HepatitisNeuzeitliche Sicherungen bei BluttransfusionenViral HepatitisPost-transfusion Hepatitis 1 June 1950Volume 32, Issue 6Page: 1019-1027KeywordsHepatitisHepatitis AHepatitis A virusHepatitis C virusHepatitis D virusInfectious diseasesInfectious hepatitisInoculationSurgeonsViral diseases ePublished: 1 December 2008 Issue Published: 1 June 1950 PDF downloadLoading ...